Emerald Therapeutics Secures Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5eb500ad-b980-4865-a20a-6c16cc16116e - Date
7/1/2014 - Company Name
Emerald Therapeutics - Mailing Address
3475-M Edison Way Menlo Park, CA 94025 USA - Company Description
Emerald Therapeutics is a venture backed Silicon Valley start-up pioneering massively disruptive therapeutic strategies. - Website
http://www.emeraldtherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Series B - Proceeds Purposes
The company also announced the release of its first product: the Emerald Cloud Laboratory (ECL). The ECL is a state-of-the-art life sciences laboratory that scientists can remotely access via the Internet where automated robotics conduct experiments exactly as specified by the user. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
